Australia - English - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - sodium fluoride, quantity: 1 mg/ml - injection, powder for - excipient ingredients: stannous fluoride - indications as at 25 september 1996: technetium (99mtc) labelled leucocytes may be used to image acute inflammation or infection.

Malta - English - Medicines Authority

iason gmbh feldkirchner str. 4, a-8054 graz, austria - fluorocholine - solution for injection - fluorocholine (18-f) 100 mbq/ml - diagnostic radiopharmaceuticals

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iason labormedizin gmbh & co. kg - sodium fluoride (18 f) 2 gbq/ml - solution for injection - 2 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iason labormedizin gmbh & co. kg - sodium fluoride (18 f) 2 gbq/ml - solution for injection - 2 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - calcium gluconate - solution for injection - 100mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - chromic chloride hexahydrate, quantity: 5.33 microgram/ml; ferric chloride hexahydrate, quantity: 540 microgram/ml; sodium selenite, quantity: 17.29 microgram/ml; sodium fluoride, quantity: 210 microgram/ml; cupric chloride dihydrate, quantity: 102.3 microgram/ml; potassium iodide, quantity: 16.6 microgram/ml; sodium molybdate dihydrate, quantity: 4.85 microgram/ml; manganese chloride tetrahydrate, quantity: 19.79 microgram/ml; zinc chloride, quantity: 1.05 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; xylitol - to meet basal to moderately increased requirements of trace elements in parenteral nutrition in adults, when either oral or enteral nutrition is inappropriate

United States - English - NLM (National Library of Medicine)

petnet solutions, inc. - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fl

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - sodium stibogluconate - solution for injection - 100mg/1ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - sulfur hexafluoride - injection, powder, for solution - 8 microlitres/ml - sulfur hexafluoride 8 microlitres/ml

United States - English - NLM (National Library of Medicine)

global isotopes, llc d/b/a zevacor molecular - fluoride ion f-18 (unii: 4m4we5n2ge) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 10 mci in 1 ml - sodium fluoride f18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk.  because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium